.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Doctor Solomon's is stocked at 547 licensed dispensaries across Illinois, New Jersey, and 9 other states, 113 of them in Illinois, with the deepest coverage in Chicago, Springfield, Quincy, East Dubuque, and Joliet. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Doctor Solomon's category mix tilted toward Topical at 38.47% share and Tincture & Sublingual at 34.40%, while Concentrates accounted for 27.14% share; the YoY split was uneven, with Topical down 25.55% and Tincture & Sublingual down 4.65%, versus Concentrates up 16.29%. Month over month, the divergence persisted: Topical fell 11.45% and Tincture & Sublingual declined 4.34%, while Concentrates grew 8.66%. Despite an average price drop of 12.43% YoY to $27.01, overall brand sales were down 10.12% YoY, implying that unit gains could not offset volume losses in larger legacy segments while Concentrates expansion partially cushioned the decline.
The pivot toward Concentrates growth paired with a rank of 11 in Maryland Concentrates suggests a niche where the brand is better aligned with current demand, as the 16.29% YoY and 8.66% MoM gains contrast with double‑digit Topical contraction of 25.55% YoY and 11.45% MoM. With Tincture & Sublingual still holding 34.40% share but slipping 4.65% YoY, the mix skews toward categories with price-sensitive headwinds, while Concentrates at 27.14% share is the momentum pocket; this implies the brand’s near-term positioning benefits from reallocating assortment and promo depth toward Concentrates while containing share erosion in Topical.
Competitive Landscape
Doctor Solomon's sits at rank #11 in MD Concentrates in September 2026, improving 5 positions year over year from #16 while holding flat versus three months ago at #11, and this follows a prior peak at #9 in October 2024. Competitive movement is upward at the top end: District Cannabis held #1 year over year with a 46.4% sales increase, while Grassroots advanced from #4 to #2 with 41.6% YoY growth, indicating Doctor Solomon's relative gain of 5 ranks is outpaced by rivals gaining 2–3 ranks at materially higher growth rates. With Nature's Heritage moving from #5 to #3 alongside 39.5% YoY growth and Evermore Cannabis Company slipping from #2 to #4 despite a 2.2% YoY sales increase, the mix suggests Doctor Solomon's stabilization near #11 risks entrenchment below the top 10 unless its share acceleration exceeds competitor trajectories.
Notable Products
THC/CBN 1:1 Doze Drops Tincture (50mg THC, 50mg CBN, 15ml) posted the steepest decline at -16.9% month over month while holding rank 2, signaling pressure in Tincture & Sublingual even as rank stability lingers. The CBD/THC 1:1 Restore Transdermal Lotion (200mg CBD, 200mg THC, 1.8oz) remained rank 1 but fell -25.2% MoM, and the CBD/THC 1:1 Restore Transdermal Lotion (100mg CBD, 100mg THC, 1oz) slipped -29.2% at rank 3, with Topicals comprising four of the top ten and tilting the mix toward transdermal formats despite pullbacks. CBD/THC 3:1 Unwind Transdermal Balm (135mg CBD, 45mg THC) was the lone Topical with a positive move at +5.3% MoM at rank 8, contrasting with OG Kush RSO Syringe (1g) down -13.4% at rank 6, implying consumers are sorting within Topicals toward differentiated ratios while legacy RSOs retrench. The pattern points to a portfolio reliant on Topicals for rank leadership but facing elasticity at higher volumes, suggesting near-term gains will come from mix shifts within transdermal ratios rather than broad category expansion.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
